Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan
· Delayed Price · Currency is TWD 33.10
+0.30 (0.91%)
Apr 29, 2026, 1:17 PM CST
Sofiva Genomics Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -9.36 | 18.43 | 11.53 | 42.78 | 56.98 | Upgrade
|
| Depreciation & Amortization | 41.61 | 41.62 | 41.34 | 42.79 | 41.95 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | - | - | -0.02 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -23.3 | -25.35 | -23.67 | -41.9 | -31.05 | Upgrade
|
| Stock-Based Compensation | -0.01 | -0.73 | 1.07 | 2.68 | 2.87 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | - | 0 | -0.49 | -0.14 | Upgrade
|
| Other Operating Activities | 1.39 | 8.46 | -3.92 | -2.99 | 1.58 | Upgrade
|
| Change in Accounts Receivable | 2.94 | 5.6 | -2.23 | 0.94 | -12.39 | Upgrade
|
| Change in Inventory | 11.55 | -4.61 | 15.29 | -15.52 | 8.55 | Upgrade
|
| Change in Accounts Payable | 0.17 | -9.25 | -18.89 | -3.64 | 7.72 | Upgrade
|
| Change in Unearned Revenue | -0.59 | 1 | -1.34 | -0.58 | -0.56 | Upgrade
|
| Change in Other Net Operating Assets | -9.07 | -0.5 | 4.5 | -6.92 | 4.56 | Upgrade
|
| Operating Cash Flow | 15.36 | 34.69 | 23.7 | 17.14 | 80.07 | Upgrade
|
| Operating Cash Flow Growth | -55.73% | 46.38% | 38.30% | -78.60% | 31.65% | Upgrade
|
| Capital Expenditures | -1.16 | -16.92 | -21.01 | -33.53 | -8.16 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | - | - | 0.1 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -7 | -7.2 | -3.55 | -2.17 | -4.49 | Upgrade
|
| Investment in Securities | - | 9.13 | 7.93 | -20.95 | - | Upgrade
|
| Other Investing Activities | -6.33 | 4.33 | 6.65 | 3.07 | 2.62 | Upgrade
|
| Investing Cash Flow | -14.44 | -10.66 | -9.99 | -53.48 | -10.03 | Upgrade
|
| Long-Term Debt Repaid | -15.25 | -15.81 | -14.74 | -15.75 | -15.54 | Upgrade
|
| Total Debt Repaid | -15.25 | -15.81 | -14.74 | -15.75 | -15.54 | Upgrade
|
| Net Debt Issued (Repaid) | -15.25 | -15.81 | -14.74 | -15.75 | -15.54 | Upgrade
|
| Issuance of Common Stock | - | 12.07 | - | - | 1.12 | Upgrade
|
| Common Dividends Paid | -6.48 | -4.27 | -21.36 | -42.73 | -29.77 | Upgrade
|
| Other Financing Activities | -0.55 | -0.55 | -0.57 | -0.18 | -0 | Upgrade
|
| Financing Cash Flow | -22.28 | -8.57 | -36.67 | -58.65 | -44.19 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.11 | -0.19 | -0.05 | -0.18 | 0.29 | Upgrade
|
| Net Cash Flow | -21.47 | 15.27 | -23.01 | -95.18 | 26.14 | Upgrade
|
| Free Cash Flow | 14.2 | 17.77 | 2.69 | -16.4 | 71.91 | Upgrade
|
| Free Cash Flow Growth | -20.11% | 560.18% | - | - | 58.55% | Upgrade
|
| Free Cash Flow Margin | 3.68% | 3.92% | 0.58% | -3.31% | 14.14% | Upgrade
|
| Free Cash Flow Per Share | 0.66 | 0.82 | 0.13 | -0.77 | 3.38 | Upgrade
|
| Cash Interest Paid | 0.8 | 1.07 | 1.24 | 1.44 | 1.69 | Upgrade
|
| Cash Income Tax Paid | -0.32 | -3.23 | 1.34 | 7.61 | 5.19 | Upgrade
|
| Levered Free Cash Flow | 16.9 | 10.12 | 2.66 | -20.41 | 63.61 | Upgrade
|
| Unlevered Free Cash Flow | 17.43 | 10.81 | 3.47 | -19.48 | 64.7 | Upgrade
|
| Change in Working Capital | 5 | -7.75 | -2.66 | -25.72 | 7.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.